Camille D Samuels's Net Worth

-$1.5 Million

Estimate Recalculated Jul 18, 2024 04:07PM EST

Who is Camille D Samuels?

Camille D Samuels does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, Alexza Pharmaceuticals Inc., REGENXBIO Inc., Unity Biotechnology, Inc., Transcept Pharmaceuticals Inc, Achaogen Inc, and HELICOS BIOSCIENCES CORP.

SEC CIK

Camille D Samuels's CIK is 0001354034

Past Insider Trading and Trends

2012 was Camille D Samuels's most active year for acquiring shares with 19 total transactions. Camille D Samuels's most active month to acquire stocks was the month of September. 2012 was Camille D Samuels's most active year for disposing of shares, totalling 21 transactions. Camille D Samuels's most active month to dispose stocks was the month of September. 2007 saw Camille D Samuels paying a total of $999,999.00 for 2,147,772 shares, this is the most they've acquired in one year. In 2012 Camille D Samuels cashed out on 2,590,159 shares for a total of $919,768.08, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KYTHERA BIOPHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.69K
—
—
0
Oct 1
Form 4
-1.79%
-250.00
$74.72
-$18,679.50
13.69K
Scheduled
Sep 1
Form 4
-1.76%
-250.00
$74.51
-$18,628.50
13.94K
Scheduled
Aug 3
Form 4
-1.73%
-250.00
$75.18
-$18,795.00
14.19K
Scheduled
Jul 1
Form 4
—
0
—
—
0
Jun 2
Form 4
-1.70%
-250.00
$49.97
-$12,492.50
14.44K
Scheduled
Jun 1
Form 4
-1.67%
-250.00
$44.72
-$11,178.90
14.69K
Scheduled
May 1
Form 4
-1.65%
-250.00
$48.93
-$12,232.50
14.94K
Scheduled
Apr 1
Form 4
-1.62%
-250.00
$40.51
-$10,126.50
15.19K
Scheduled
Mar 2
Form 4
-1.59%
-250.00
$37.31
-$9,328.00
15.44K
Scheduled
Feb 2
Form 4
-1.57%
-250.00
$36.70
-$9,175.00
15.69K
Scheduled
Jan 16
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Oct 10
Form 4
+24.39%
2.39M
$13.72
$433.47
12.17M
Oct 16
Form 3
—
0
—
—
0
No matching records found

Alexza Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.18M
—
—
2.18M
Mar 13
Form 3
—
0
—
—
0
No matching records found

REGENXBIO Inc. (RGNX) Snapshot price: $13.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found

Unity Biotechnology, Inc. (UBX) Snapshot price: $1.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
May 2
Form 3
—
0
—
—
0
No matching records found

Transcept Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Jan 14
Form 4
—
0
—
—
0
Feb 12
Form 4/A
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Jan 17
Form 4
∞
2.07M
—
—
2.07M
May 15
Form 3
—
0
—
—
0
No matching records found